Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 31;19(2):367-387.
doi: 10.9758/cpn.2021.19.2.367.

'Z-trip'? A Comprehensive Overview and a Case-series of Zolpidem Misuse

Laura Orsolini  1   2 , Stefania Chiappini  2 , Paolo Grandinetti  3 , Angelo Bruschi  4   5   6 , Roberta Testa  7 , Alessandra Provenzano  8 , Domenico De Berardis  9   10 , Umberto Volpe  1
Affiliations

'Z-trip'? A Comprehensive Overview and a Case-series of Zolpidem Misuse

Laura Orsolini et al. Clin Psychopharmacol Neurosci. .

Abstract

Although believed safer compared to short-acting benzodiazepines (BZD), in the past few years a growing concern has developed relating to the abuse of Z-drugs, and specifically of zolpidem. Here we aim to review the evidence for the misuse of zolpidem and describe several related cases collected in Italy. A comprehensive overview is here carried by using several databases, and by combining the search strategy of free text terms and exploding a range of MESH headings relating to the topics of Zolpidem and Abuse and/or Misuse as follows: ((Zolpidem[Title/Abstract]) AND (Abuse[Title/Abstract]) OR (Misuse[Title/Abstract])), without time and/or language restrictions. Furthermore, a case series of 8 cases of zolpidem misuse and/or abuse, collected in different Italian psychiatric settings (psychiatric public hospital, psychiatric private rehabilitation clinic, and private practice), have been here described. According to our findings, zolpidem should be prescribed with the same caution as BZDs, especially in patients with a history of drug abuse or in the elderly. Behavioural modifications, including bizarre behaviours, psychomotor agitation, sleep-related complex behaviours have been reported. Monitoring of zolpidem use in selected populations is warranted. Psychiatrists and physicians should be aware of the misuse potential of zolpidem and adopt measures restricting its use.

Keywords: Drug misuse; Drug prescription misuse; Hallucinations.; Z drugs; Zolpidem.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

References

    1. National Institute for Health and Care Excellence (NICE), author Guidance on the use of zaleplon, zolpidem and zopiclone for the shortterm management of insomnia. National Institute for Health and Care Excellence (NICE); London: 2004.
    1. Marsden J, White M, Annand F, Burkinshaw P, Carville S, Eastwood B, et al. Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England. Lancet Psychiatry. 2019;6:935–950. doi: 10.1016/S2215-0366(19)30331-1. - DOI - PMC - PubMed
    1. Wilson S, Anderson K, Baldwin D, Dijk DJ, Espie A, Espie C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. J Psychopharmacol. 2019;33:923–947. doi: 10.1177/0269881119855343. - DOI - PubMed
    1. Swainston Harrison T, Keating GM. Zolpidem: a review of its use in the management of insomnia. CNS Drugs. 2005;19:65–89. doi: 10.2165/00023210-200519010-00008. - DOI - PubMed
    1. Siriwardena AN, Qureshi Z, Gibson S, Collier S, Latham M. GPs’ attitudes to benzodiazepine and ‘Z-drug’ prescribing: a barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract. 2006;56:964–967. - PMC - PubMed